An Open-label, Single-Centre Study to Assess the Pharmacokinetics of R406 in Healthy Volunteers When Fostamatinib Disodium 150 mg is Administered Alone and in Combination With Verapamil.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Fostamatinib; Verapamil
- Indications Angina pectoris; Arrhythmias; B cell lymphoma; Chronic lymphocytic leukaemia; Hypertension; Rheumatoid arthritis; Solid tumours; T cell lymphoma; Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 06 Jan 2016 Results of this and other two phase I studies published in the Drugs in R and D
- 22 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2010 Actual initiation date added to 1 Sep 2010 as reported by ClinicalTrials.gov.